Reps. Upton and Dingell on Solving America’s Opioid Crisis

Writing this morning for the Detroit Free Press, Reps. Fred Upton (R-MI) and Debbie Dingell (D-MI) reinforce the need for innovation to help combat opioid abuse and addiction in America. As they state:

“While it’s true there is no magic-wand to address this issue, we must recognize that if we’re going to achieve an addiction free nation, it will depend on smart science and a regulatory environment that promotes pain management alternatives.”

Achieving an addiction free America will not happen overnight. In fact, as a nation we’re spending more than $500 billion annually in health and social costs to combat this epidemic. But as Reps. Upton and Dingell explain, smart science and a regulatory environment that promotes pain management alternatives can help get our nation back on track.

“We can innovate our way out of the opioid crisis, but to do so we must face the challenges that stand in our way. It’s essential that we speed the commercialization of new, non-addictive painkillers – and ensure that neuroscience breakthroughs to treat opioid addiction are more accessible to patients.”

Consistent with the recommendations BIO recently released, Reps. Upton and Dingell agree that access to novel, safer treatments needs to be a top priority if we’re going to end this public health crisis. And as we’ve pointed out before, this can be achieved by breaking the barriers that impede patients’ access to the most appropriate treatments – including medication assisted treatment – and stimulating the development of novel and safer therapies to manage this growing public health crisis.

To read the full op-ed in the Detroit Free Press, click here. For more on BIO’s commitment to developing solutions that will allow for an addiction free America, click here.

 

 

 

 

TNB Financial Buys Shares of 10786 iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

iShares NASDAQ Biotechnology Index logo TNB Financial purchased a new stake in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) in the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 10,786 shares of the financial services provider’s stock, valued at …

Bill Gates Calls GMOs ‘Perfectly Healthy’ – And Scientists Say He’s Right

Bill Gates has a message for those advocating against genetically modified organisms: I’m disappointed.

Business Insider science correspondent Erin Brodwin explains:

In a Reddit “Ask Me Anything” post on Tuesday, Gates said that not only does he view genetically modified foods as “perfectly healthy,” but that he sees them as a promising tool in a wider array of resources in the fight to reduce world hunger.

“GMO foods are perfectly healthy and the technique has the possibility to reduce starvation and malnutrition when it is reviewed in the right way,” Gates wrote. “I don’t stay away from non-GMO foods but it is disappointing that people view it as better.”

Gates’ view may strike some as controversial, as many people think that genetically modified foods are dangerous.

In recent years, companies have submitted more than 43,000 products to the Non-GMO Project, an organization that certifies products that don’t contain genetically modified ingredients. And sales of such products are skyrocketing – today, they represent more than $22 billion in yearly sales, the organization says.

But Gates’ stance is in line with that of most scientists who study the topic.

Organizations like the National Academy of Sciences, the American Association for the Advancement of Science, and the European Commission have publicly said genetically modified foods are safe to eat. A large 2013 study on GMOs found no “significant hazards directly connected with the use of genetically engineered crops.”

And nearly all the food we eat today has been genetically modified in some way. Dozens of crops, from corn to watermelon, have been selectively bred for thousands of years to give us the traits we find desirable, like large amounts of sweet, edible flesh, or small seeds.

And many other products – some of them life-saving – might not exist without genetically modified ingredients.

Insulin, the medication that people with diabetes depend on to regulate their blood sugar, is made with such ingredients, while the cotton used to make the shirt you’re wearing was most likely genetically modified.

Several experts say the “GMO” label does a disservice to the products made with genetically modified ingredients. The process of genetic modification is a breeding method, much like other recent advances in agriculture.

“What are we labeling here, DNA?” Alison Van Eenennaam, a professor of animal genomics at the University of California at Davis, recently told Business Insider. “There’s DNA in everything, so good luck with that.”

We’re Reaching a Tipping Point in the Biobased Economy

In a piece for Biofuels Digest, BIO’s Executive Vice President, Industrial & Environmental Section, Brent Erickson (@BErickson_BIO) argues that the biobased economy is at a tipping point. With an estimated $355.28 billion in global economic value, Erickson dives into the biobased economy’s impact to date and the U.S. federal and state policies that must be addressed to keep up with the industry’s rapid growth.

Read the full piece below and be sure to check out Brent Erickson’s presentation on the biobased economy at Biofuels Digest’s Advanced Biofuels Leadership Conference on March 1, 2018 in Washington, D.C.

Also, don’t forget to register for BIO’s World Congress on Industrial Biotechnology in Philadelphia, July 16-19, 2018. BIO’s World Congress is the world’s largest conference on industrial biotechnology.

BIO is the only trade association that advocates for the diverse policies that support the entire biobased economy – the full value chain of technologies and infrastructure to convert renewable, low-carbon, low-cost feedstocks and waste streams into value-added consumer products, including renewable chemicals and biofuels.

The unifying factor among BIO’s members is their use of biotechnology in their drive to commercialize new, advanced and more sustainable technologies. That mission brings together researchers, producers and companies from across the entire biobased economy. And the value chain is constantly growing and changing, driven by the rapid pace of innovation in industrial biotechnology. It seems there are always new, innovative companies emerging to develop first-of-a-kind products, technologies and new feedstocks.

At the same time, after some fits and starts, the biobased economy is approaching a tipping point in its growth and maturation. Already, a number of companies have successfully commercialized technologies for renewable chemicals, built biorefineries and created supply chains – and turned their attention to commercializing their next product. The economic impact is evident. Bioeconomy Capital estimates that renewable chemicals now generate the equivalent of around one half of 1 percent (0.5%) of U.S. GDP, while petrochemicals generate around 3 percent. Put a different way, for every $7 contributed to the U.S. economy by the chemical industry, $1 is coming from renewable chemicals.

Several studies and market analyses have aimed to calculate the economic value of the entire biobased economy. However, no single study captures all of the economic impacts across the full value chain.

Bioeconomy Capital also estimates that the U.S. industrial biotechnology sector – which they define to include renewable chemicals, nutritional ingredients and biotech R&D industries, among others – generated more than $140 billion in business-to-business revenue in 2016. The sector experienced tremendous growth since 2012, when total revenue was $105 billion, according to their report.

A USDA study shows that direct revenue from renewable chemicals and biobased products (those eligible for the BioPreferred® program) grew to $127 billion, providing direct employment to 1.53 million U.S. workers. With a strong multiplier for job creation, the biobased product sector’s indirect economic impact reached $393 billion in 2014. The two studies cover some of the same industries, but not the entire biobased economy.

Looking at several studies that measure various elements of the value chain, BIO calculates that the global economic value of the biobased economy – including industrial biotechnology, renewable chemicals and polymers, biofuels, enzymes and biobased materials – is $355.28 billion. The United States generates 58 percent of the global value of biased manufacturing, or more than $205 billion. And that economic activity supports employment for 1.66 million U.S. workers.

As industry leaders, we need to help policy makers understand that the entire value chain creates economic opportunities – policy should include support at every stage to ensure that the biobased economy reaches critical mass. For instance, the U.S. tax code should recognize renewable chemicals to keep the United States competitive in commercializing this homegrown technology. A top priority for BIO is the Qualified Renewable Chemicals Tax Credit. We have been building congressional support for this critical legislation, which will provide renewable chemicals similar tax credits enjoyed by other alternative energies. Congress must recognize other countries are providing incentives for companies to build commercial production capacity – those countries will capture the jobs and the economic growth from the biobased economy, unless the United States levels the playing field.

BIO is leading the way to secure reauthorization of the Farm Bill energy title programs that will develop and incentivize investment in the biobased economy. Congress should consider changing the name of that title, because it is now broader than just energy. The Farm Bill energy title programs have supported the emergence of the biobased economy here in the United States and compiled a record of success that deserves to be continued.

Reauthorization of these programs will provide crucial access to capital and marketspace for companies developing renewable chemicals; those are key ingredients for building manufacturing infrastructure.

Industrial biotechnology will continue to drive growth in the biobased economy. It’s difficult to predict where innovation will take us. But the economic impact is becoming evident; the biobased economy is a measurable percentage of overall U.S. productivity. BIO is working to ensure U.S. federal and state policy keeps up with this growth.

Kalbe Farma inaugurates first biotech factory

Kalbe Farma inaugurates first biotech factory President Joko “Jokowi” Widodo speaks at the inauguration of Kalbe Farma’s new biotechnology-based factory in Cikarang, West Java, on Tuesday. (JP/ktm) …

Biotech is key to Achieving International Trilateral Group’s Goals

This week in Geneva three key UN agencies are meeting to address and advance their shared mission of achieving the UN Sustainable Development Goals.

This is the seventh technical symposium organized by the WHO, WIPO and WTO dedicated to achieving the ambitious goals of UN Sustainable Development Goal 3: Ensure healthy lives and promote well-being for all at all ages.

http://www.un.org/sustainabledevelopment/sustainable-development-goals/John Brennan, Secretary General of EuropaBio and a representative of the International Council of Biotechnology Associations, joined a panel discussion on Monday, February 26th at the symposium where he outlined the critical role biotechnology innovation will continue to play as we work to achieve the UN Sustainable Development Goals. Of note, John emphasized the need for greater support of policies that BIO recognizes as fundamental and vital elements of domestic and international policy that fuel innovation. This includes the need for improved and unified intellectual property protection standards and the reduction of trade barriers that impede access such as regulatory delays.

BIO share’s John’s view of the importance of working “together” with private and public institutions, as well as NGOs, to achieve the SDGs.

Harnessing the Power of Nature: How Agrobacterium Has Advanced Food and Agriculture Innovation

Editor’s Note: As part of BIO’s 25th Anniversary celebration we will be spotlighting biotechnology innovations that have made a major impact over the past 25 years. This “Innovation Series” will publish on the 25th of every month throughout 2018. In the second installment we spotlight food and agriculture. 

On any given day, you can walk into any American grocery store and the produce section is overflowing with fresh fruits and vegetables. Similarly, shelf items like soybean and canola oil, cornstarch and sugar are never hard to come by. It’s hard to envision a time – outside a natural disaster – when these foods are not readily available.

These advances are the result of hardworking men and women across rural America who utilize decades of agriculture innovation to ensure that American consumers have healthy food for themselves and their families. And yet the battle to ensure food security for hundreds of millions of people in our world is far from won. So, how do we meet our future needs for food, fuel and fiber?

Already, biotechnology has dramatically improved the way in which we grow food.  Global acreage of biotech crops increased 110-fold over the past two decades (from 4.2 million acres in 1996 to 4.58 million acres in 2016) making it the fastest adopted crop technology in modern history.

The benefits provided by biotechnology have helped 18 million farmers increase crop productivity, conserve biodiversity, reduce chemical inputs, CO2 emissions, soil erosion and water use while providing societal gains and billions of meals – especially in the developing world.

What many don’t know, however, is that these advancements would not be possible without the discovery, and subsequent harnessing, of a soil microbe called Agrobacterium. Commonly found in nature, this microbe has the ability to move some of its genetic material into the roots – and into the DNA – of plants. As a result, the plant takes on the characteristics of the gene that has been transferred. This process has been occurring naturally in the environment since before man was in caves.

Fast forward to the late 1970s when scientist Mary-Dell Chilton, and a handful of others, began researching Agrobacterium, hypothesizing that the microbe could serve as a vehicle to insert desirable genes into plants. Essentially, the scientists believed that by removing some of the microbe’s genetic material that they didn’t want and putting in genetic material that they were interested in, they could effectively modify the plant as they wish. And unlike older methods for altering crops, such as traditional plant breeding, improvements made using Agrobacterium carried the promise of being faster, direct and more precise. A few years later, Chilton and her team affirmed this hypothesis when they successfully developed the first transgenic plant using this exciting new technique.

Not long after this discovery, scientists began experimenting further, modifying crops in ways that were beneficial to farmers, consumers and/or the environment. For example, scientists modified corn to contain proteins that made the crop resistant to caterpillars, much like the proteins sprayed on organic crops. Now known as B.t. corn, this modification allowed farmers to increase crop yields and dramatically lower their use of chemical insecticides.

Other crops have been modified to use less resources like water, which helps farmers cope with climate change. Additionally, some crops have been modified to carry extra nutrients like Vitamin A, which could have global impact on developing regions whose populations are malnourished.

Thanks to the discovery of Agrobacterium, there are 10 crops available today that have been improved through gene modification: corn, squash, cotton, soybean, papaya, alfalfa, sugar beets, canola, apple and the potato. Moreover, many of these crops are found in essential food items, such as canned vegetables, oils, sugars and soy-based milks and proteins.

In 2013, Chilton (Syngenta) along with two other scientists, Robert Fraley (Monsanto) and Marc Van Montagu (Institute of Plant Biotechnology Outreach at Ghent University in Belgium), received the World Food Prize for their work in discovering the capabilities of Agrobacterium. The award recognizes individuals who have improved the quantity and availability of food throughout the world.

At the award ceremony, then-Secretary of State John Kerry underscored the significance of the innovation, stating “we save money and we save the environment and we save lives. It is a virtuous cycle. And through innovation, we believe we can help alleviate the level of hunger and malnutrition today, but more than that, we can, hopefully, live up to our responsibilities for the future.”

As evidence by the crops on the market today, the exploitation of Agrobacterium has already had immeasurable impacts for farmers, consumers and the environment. And as Kerry alluded to in his address, biotechnology will continue to improve the way we grow food – and other necessary crops – for future generations.

51599 Shares in ProShares Ultra Nasdaq Biotechnology ETF (BIB) Purchased by Virtu Financial LLC

ProShares Ultra Nasdaq Biotechnology ETF logo Virtu Financial LLC bought a new stake in shares of ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought …

How To Paint Over Wallpaper – Today’s Homeowner

How To Paint Over Wallpaper

To successfully paint over wallpaper, you need to first confirm that the wallpaper is smooth and well attached to the wall. Begin by filling any holes or dents in the surface with drywall joint compound. First, use the drywall knife to scrape off any tags of paper around the hole. Then use the handle to […]

Swiss biotech group Lonza admits 250 mercury poisoning cases before 1950

Swiss chemicals and biotechnology group Lonza acknowledged Saturday that up to 250 of its employees had suffered from mercury poisoning before 1950. The revelation came after a joint investigation by public broadcaster RTS and three Swiss newspapers showed that a large number of Lonza …

1 29 30 31 32 33 46